Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial

BackgroundThe titration pressure of continuous positive airway pressure (CPAP) is important in patients with obstructive sleep apnea (OSA). This study aimed to understand the difference between drug-induced sleep endoscopy (DISE)-guided CPAP titration and conventional sleep center (CSC) CPAP titrati...

Full description

Bibliographic Details
Main Authors: Tsai-Yu Wang, Yu-Chen Huang, Ting-Yu Lin, Yung-Lun Ni, Yu-Lun Lo
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.882465/full
_version_ 1811247926311124992
author Tsai-Yu Wang
Tsai-Yu Wang
Yu-Chen Huang
Ting-Yu Lin
Ting-Yu Lin
Yung-Lun Ni
Yu-Lun Lo
Yu-Lun Lo
author_facet Tsai-Yu Wang
Tsai-Yu Wang
Yu-Chen Huang
Ting-Yu Lin
Ting-Yu Lin
Yung-Lun Ni
Yu-Lun Lo
Yu-Lun Lo
author_sort Tsai-Yu Wang
collection DOAJ
description BackgroundThe titration pressure of continuous positive airway pressure (CPAP) is important in patients with obstructive sleep apnea (OSA). This study aimed to understand the difference between drug-induced sleep endoscopy (DISE)-guided CPAP titration and conventional sleep center (CSC) CPAP titration in patients with OSA.MethodsIn this randomized, controlled, and single-blind crossover trial, we compared the effects of 1-month CPAP treatment in patients with OSA with either DISE-guided CPAP titration or CSC CPAP titration. Twenty-four patients with OSA were recruited for the study. All patients underwent polysomnography, DISE-guided CPAP titration, and accommodation. Initially, patients were randomly assigned to receive either DISE-guided CPAP titration or CSC CPAP treatment for the first month. They were then switched to other treatments in the second month. The Epworth sleepiness scale (ESS) score was recorded at baseline, 1 and 2 months.ResultsThe upper limit of the pressure of DISE-guided titration and CSC CPAP titration was not significantly different (13.9 ± 0.7 vs. 13.5 ± 0.5 cm H2O; P = 0.92). The residual apnea-hypopnea index and compliance were also not significantly different between the groups. ESS score significantly improved from baseline to 1 month after CPAP treatment in both groups. Both epiglottis (anterior-posterior collapse) and tongue base collapse were significantly associated with 95% CPAP pressure (P = 0.031 and 0.038, respectively). After multivariate regression analyses, the epiglottis (anterior-posterior collapse) was an independent factor for 95% CPAP pressure. The incidence rate of bradycardia was 58.3%, which is a safety concern for DISE. Despite the high incidence of bradycardia, all patients with bradycardia recovered with proper management.ConclusionBoth modalities were comparable in terms of establishing the pressure settings required to treat patients. Further large-scale studies are required to confirm these results.Trial registrationhttps://clinicaltrials.gov/, NCT03523013.
first_indexed 2024-04-12T15:19:08Z
format Article
id doaj.art-08fa7b6879ee4bb5a2f10bdd89fb181b
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-04-12T15:19:08Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-08fa7b6879ee4bb5a2f10bdd89fb181b2022-12-22T03:27:32ZengFrontiers Media S.A.Frontiers in Neurology1664-22952022-06-011310.3389/fneur.2022.882465882465Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover TrialTsai-Yu Wang0Tsai-Yu Wang1Yu-Chen Huang2Ting-Yu Lin3Ting-Yu Lin4Yung-Lun Ni5Yu-Lun Lo6Yu-Lun Lo7Department of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Main Branch, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Main Branch, Taoyuan, TaiwanDepartment of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Main Branch, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanDepartment of Chest Medicine, Buddhist Tzu Chi General Hospital, Taichung Branch, Taichung, TaiwanDepartment of Thoracic Medicine, Chang Gung Memorial Hospital Linkou Main Branch, Taoyuan, TaiwanSchool of Medicine, Chang Gung University, Taoyuan, TaiwanBackgroundThe titration pressure of continuous positive airway pressure (CPAP) is important in patients with obstructive sleep apnea (OSA). This study aimed to understand the difference between drug-induced sleep endoscopy (DISE)-guided CPAP titration and conventional sleep center (CSC) CPAP titration in patients with OSA.MethodsIn this randomized, controlled, and single-blind crossover trial, we compared the effects of 1-month CPAP treatment in patients with OSA with either DISE-guided CPAP titration or CSC CPAP titration. Twenty-four patients with OSA were recruited for the study. All patients underwent polysomnography, DISE-guided CPAP titration, and accommodation. Initially, patients were randomly assigned to receive either DISE-guided CPAP titration or CSC CPAP treatment for the first month. They were then switched to other treatments in the second month. The Epworth sleepiness scale (ESS) score was recorded at baseline, 1 and 2 months.ResultsThe upper limit of the pressure of DISE-guided titration and CSC CPAP titration was not significantly different (13.9 ± 0.7 vs. 13.5 ± 0.5 cm H2O; P = 0.92). The residual apnea-hypopnea index and compliance were also not significantly different between the groups. ESS score significantly improved from baseline to 1 month after CPAP treatment in both groups. Both epiglottis (anterior-posterior collapse) and tongue base collapse were significantly associated with 95% CPAP pressure (P = 0.031 and 0.038, respectively). After multivariate regression analyses, the epiglottis (anterior-posterior collapse) was an independent factor for 95% CPAP pressure. The incidence rate of bradycardia was 58.3%, which is a safety concern for DISE. Despite the high incidence of bradycardia, all patients with bradycardia recovered with proper management.ConclusionBoth modalities were comparable in terms of establishing the pressure settings required to treat patients. Further large-scale studies are required to confirm these results.Trial registrationhttps://clinicaltrials.gov/, NCT03523013.https://www.frontiersin.org/articles/10.3389/fneur.2022.882465/fullCPAPOSAoutcomeCPAP pressuredrug-induced sleep endoscopy (DISE)
spellingShingle Tsai-Yu Wang
Tsai-Yu Wang
Yu-Chen Huang
Ting-Yu Lin
Ting-Yu Lin
Yung-Lun Ni
Yu-Lun Lo
Yu-Lun Lo
Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
Frontiers in Neurology
CPAP
OSA
outcome
CPAP pressure
drug-induced sleep endoscopy (DISE)
title Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
title_full Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
title_fullStr Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
title_full_unstemmed Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
title_short Outcome of CPAP Titration for Moderate-to-Severe OSA Under Drug-Induced Sleep Endoscopy: A Randomized Controlled Crossover Trial
title_sort outcome of cpap titration for moderate to severe osa under drug induced sleep endoscopy a randomized controlled crossover trial
topic CPAP
OSA
outcome
CPAP pressure
drug-induced sleep endoscopy (DISE)
url https://www.frontiersin.org/articles/10.3389/fneur.2022.882465/full
work_keys_str_mv AT tsaiyuwang outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT tsaiyuwang outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT yuchenhuang outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT tingyulin outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT tingyulin outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT yunglunni outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT yulunlo outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial
AT yulunlo outcomeofcpaptitrationformoderatetosevereosaunderdruginducedsleependoscopyarandomizedcontrolledcrossovertrial